Xtant Medical Holdings Stock Alpha and Beta Analysis
| XTNT Stock | USD 0.40 0.01 2.44% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Xtant Medical Holdings. It also helps investors analyze the systematic and unsystematic risks associated with investing in Xtant Medical over a specified time horizon. Remember, high Xtant Medical's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Xtant Medical's market risk premium analysis include:
Beta 1.16 | Alpha (0.87) | Risk 4.53 | Sharpe Ratio (0.09) | Expected Return (0.40) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Xtant |
Xtant Medical Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Xtant Medical market risk premium is the additional return an investor will receive from holding Xtant Medical long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Xtant Medical. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Xtant Medical's performance over market.| α | -0.87 | β | 1.16 |
Xtant Medical expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Xtant Medical's Buy-and-hold return. Our buy-and-hold chart shows how Xtant Medical performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Xtant Medical Market Price Analysis
Market price analysis indicators help investors to evaluate how Xtant Medical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Xtant Medical shares will generate the highest return on investment. By understating and applying Xtant Medical stock market price indicators, traders can identify Xtant Medical position entry and exit signals to maximize returns.
Xtant Medical Return and Market Media
The median price of Xtant Medical for the period between Tue, Sep 3, 2024 and Mon, Dec 2, 2024 is 0.57 with a coefficient of variation of 15.69. The daily time series for the period is distributed with a sample standard deviation of 0.09, arithmetic mean of 0.56, and mean deviation of 0.07. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | September 2024s Top SEHK Value Picks For Potential Growth | 09/24/2024 |
2 | 3 SEHK Stocks That May Be Undervalued By Up To 48.6 | 09/26/2024 |
3 | SEHK AK Medical Holdings Among 3 Stocks Possibly Undervalued According to Estimates | 10/10/2024 |
4 | Disposition of 105442 shares by Sean Browne of Xtant Medical at 0.59 subject to Rule 16b-3 | 10/15/2024 |
5 | SEHK Stocks That Could Be Trading Below Estimated Value In October 2024 | 10/17/2024 |
6 | Earnings To Watch Xtant Medical Holdings Inc Reports Q3 2024 Result | 11/11/2024 |
7 | Xtant Medical Reports Third Quarter 2024 Financial Results | 11/12/2024 |
8 | Xtant Medical Holdings Inc Q3 2024 Earnings Call Highlights Strong Growth Amid Challenges | 11/13/2024 |
9 | lker Biskvi Sanayi Leads This Trio Of Stocks That May Be Underestimated By The Market | 11/27/2024 |
About Xtant Medical Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Xtant or other stocks. Alpha measures the amount that position in Xtant Medical Holdings has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2021 | 2022 | 2023 | 2024 (projected) | Payables Turnover | 8.71 | 7.4 | 5.08 | 3.87 | Days Of Inventory On Hand | 287.62 | 244.23 | 375.68 | 382.25 |
Xtant Medical Upcoming Company Events
As portrayed in its financial statements, the presentation of Xtant Medical's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Xtant Medical's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Xtant Medical's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Xtant Medical. Please utilize our Beneish M Score to check the likelihood of Xtant Medical's management manipulating its earnings.
| 5th of March 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Build Portfolio with Xtant Medical
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for Xtant Stock Analysis
When running Xtant Medical's price analysis, check to measure Xtant Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xtant Medical is operating at the current time. Most of Xtant Medical's value examination focuses on studying past and present price action to predict the probability of Xtant Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xtant Medical's price. Additionally, you may evaluate how the addition of Xtant Medical to your portfolios can decrease your overall portfolio volatility.